In 2019, Vila et al. [76] demonstrated that UBE2O’s expression is universally upregulated in animal models exhibiting insulin resistance and metabolic disorders and significantly elevated in obese subjects with type 2 diabetes. Here, UBE2O is linked to type 2 diabetes mellitus.